(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
The most effective method to Pick the Best Material Organization: Insider Tips - 2Dental Embed Innovation: An Achievement in Helpful Dentistry
- 3How did Ariana Grande get her Glinda voice? I’m the man behind the magic.
- 4Merck sees over $5 billion opportunity in Cidara's experimental flu drug
- 5Spotify Wrapped and Apple Music Replay are here: Top songs, albums and artists of 2025
- Tire Brands for Senior Drivers: Guaranteeing Security and Solace
- The Most recent Microsoft Surface Genius PC: Ideal for Very good quality Planning and Gaming Needs
- True to life Authenticity d: A Survey of \Certifiable Stories\ Narrative
- Figure out How to Amplify Innovation and Infotainment Frameworks for Senior Drivers in SUVs
- Which salad do you believe is a definitive group pleaser? Vote!
- The most effective method to Plan an Incineration Administration: A Bit by bit Guide.
- Find the Specialty of Calligraphy: Dominating the Exquisite Art of Penmanship
- 6 Fun Urban areas For Seniors To Travel
- 8 Espresso Bean Starting points All over the Planet
